Moderna reports $1.2bn net loss in Q1 2024
Moderna experienced a substantial financial shift in the first quarter (Q1) of 2024, reporting a net loss of $1.2bn -…
Moderna experienced a substantial financial shift in the first quarter (Q1) of 2024, reporting a net loss of $1.2bn -…
At the 34th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global (formerly ECCMID) conference in Barcelona, Spain, drug…
At the 34th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global (formerly ECCMID) conference in Barcelona, Spain, the…
The AHF Global Public Health Institute has voiced concerns over the World Health Organization’s (WHO) proposed pandemic agreement, saying that…
Gilead Sciences has received a US Food and Drug Administration (FDA) approval for the label expansion of its human immunodeficiency…
Cidara Therapeutics has entered into a definitive agreement with Johnson & Johnson (J&) to buy back the rights to its…
The European Commission (EC) has granted marketing authorisation for Pfizer’s Emblaveo (aztreonam-avibactam), aimed at treating adults with multidrug-resistant infections where…
Nigeria has launched the new Men5CV vaccine, which offers protection against five strains of the Neisseria meningitidis bacteria (meningococcus) responsible…
Switzerland-based Basilea Pharmaceutica has received a $0.9m grant from the global non-profit, Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), to develop…
England’s NHS is calling its recent campaign to boost vaccination rates a success amidst a surge in measles, mumps, and…